Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70401 - 70425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ENPP1	5167	downregulated	Silicon Dioxide analog results in decreased expression of ENPP1 mRNA	6q23.2	A24195
Silicon dioxide	Approved	ENPP6	133121	upregulated	Silicon Dioxide analog results in increased expression of ENPP6 mRNA	4q35.1	A24194
Silicon dioxide	Approved	EOMES	8320	downregulated	Silicon Dioxide analog results in decreased expression of EOMES mRNA	3p24.1	A24194
Silicon dioxide	Approved	EP300	2033	downregulated	Silicon Dioxide results in decreased expression of EP300 mRNA	22q13.2	A24207
Silicon dioxide	Approved	EPAS1	2034	upregulated	Silicon Dioxide analog results in increased expression of EPAS1 mRNA	2p21	A24195
Silicon dioxide	Approved	EPB41L1	2036	downregulated	Silicon Dioxide results in decreased expression of EPB41L1 mRNA	20q11.23	A24196
Silicon dioxide	Approved	EPB41L2	2037	upregulated	Silicon Dioxide analog results in increased expression of EPB41L2 mRNA	6q23.1-q23.2	A24195
Silicon dioxide	Approved	EPB41L2	2037	upregulated	Silicon Dioxide results in increased expression of EPB41L2 mRNA	6q23.1-q23.2	A24196
Silicon dioxide	Approved	EPB41L4A	64097	downregulated	Silicon Dioxide analog results in decreased expression of EPB41L4A mRNA	5q22.1-q22.2	A24195
Silicon dioxide	Approved	EPB41L4A	64097	downregulated	Silicon Dioxide results in decreased expression of EPB41L4A mRNA	5q22.1-q22.2	A24196
Silicon dioxide	Approved	EPB41L4A-AS2	54508	downregulated	Silicon Dioxide analog results in decreased expression of EPB41L4A-AS2 mRNA	5q22.2	A24195
Silicon dioxide	Approved	EPB41L5	57669	downregulated	Silicon Dioxide analog results in decreased expression of EPB41L5 mRNA	2q14.2	A24195
Silicon dioxide	Approved	EPCAM	4072	downregulated	Silicon Dioxide analog results in decreased expression of EPCAM mRNA	2p21	A24195
Silicon dioxide	Approved	EPDR1	54749	upregulated	Silicon Dioxide analog results in increased expression of EPDR1 mRNA	7p14.1	A24194
Silicon dioxide	Approved	EPHA2	1969	upregulated	Silicon Dioxide analog results in increased expression of EPHA2 mRNA	1p36.13	A24195
Silicon dioxide	Approved	EPHB1	2047	upregulated	Silicon Dioxide analog results in increased expression of EPHB1 mRNA	3q22.2	A24194
Silicon dioxide	Approved	EPHB3	2049	downregulated	Silicon Dioxide analog results in decreased expression of EPHB3 mRNA	3q27.1	A24195
Silicon dioxide	Approved	EPHB6	2051	downregulated	Silicon Dioxide analog results in decreased expression of EPHB6 mRNA	7q34	A24195
Silicon dioxide	Approved	EPHB6	2051	upregulated	Silicon Dioxide analog results in increased expression of EPHB6 mRNA	7q34	A24194
Silicon dioxide	Approved	EPHX1	2052	downregulated	Silicon Dioxide analog results in decreased expression of EPHX1 mRNA	1q42.12	A24195
Silicon dioxide	Approved	EPHX2	2053	downregulated	Silicon Dioxide analog results in decreased expression of EPHX2 mRNA	8p21.2-p21.1	A24195
Silicon dioxide	Approved	EPRS	2058	downregulated	Silicon Dioxide results in decreased expression of EPRS mRNA	1q41	A24196
Silicon dioxide	Approved	EPS8	2059	downregulated	Silicon Dioxide analog results in decreased expression of EPS8 mRNA	12p12.3	A24195
Silicon dioxide	Approved	EPSTI1	94240	upregulated	Silicon Dioxide analog results in increased expression of EPSTI1 mRNA	13q14.11	A24194
Silicon dioxide	Approved	ERBB2	2064	downregulated	Silicon Dioxide analog results in decreased expression of ERBB2 mRNA	17q12	A24195

Displaying entries 70401 - 70425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability